Evidence map›Paper›PMID 40361352›Full record

ArticleCancers2025

Understanding the Impact of Deep Learning Model Parameters on Breast Cancer Histopathological Classification Using ANOVA.

Nerea Hernandez, Francisco Carrillo-Perez, Francisco M Ortuño, Ignacio Rojas, Olga Valenzuela

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nerea HernandezDepartment of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.
Francisco Carrillo-PerezDepartment of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.ORCID 0000-0003-0974-4092
Francisco M OrtuñoDepartment of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-7424-1753
Ignacio RojasDepartment of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-1033-5635
Olga ValenzuelaDepartment of Computer Engineering, Automation and Robotics, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-6034-9392

Funding

Consejería de Universidad, Investigación e Innovación C-ING-172-UGR23Ministerio de Ciencia, Innovación y Universidades PID2021-128317OB-I00
6 · The paper itself

Abstract

Artificial intelligence (AI) has the potential to enhance clinical practice, particularly in the early and accurate diagnosis of diseases like breast cancer. However, for AI models to be effective in medical settings, they must not only be accurate but also interpretable and reliable. This study aims to analyze how variations in different model parameters affect the performance of a weakly supervised deep learning model used for breast cancer detection.

methodsIn this work, we apply Analysis of Variance (ANOVA) to investigate how changes in different parameters impact the performance of the deep learning model. The model is built using attention mechanisms, which both perform classification and identify the most relevant regions in medical images, improving the interpretability of the model. ANOVA is used to determine the significance of each parameter in influencing the model's outcome, offering insights into the specific factors that drive its decision-making.

resultsOur analysis reveals that certain parameters significantly affect the model's performance, with some configurations showing higher sensitivity and specificity than others. By using ANOVA, we identify the key factors that influence the model's ability to classify images correctly. This approach allows for a deeper understanding of how the model works and highlights areas where improvements can be made to enhance its reliability in clinical practice.

conclusionsThe study demonstrates that applying ANOVA to deep learning models in medical applications provides valuable insights into the parameters that influence performance. This analysis helps make AI models more interpretable and trustworthy, which is crucial for their adoption in real-world medical environments like breast cancer detection. Understanding these factors enables the development of more transparent and efficient AI tools for clinical use.

Indexed as

ANOVAbreast cancer subtypingclassificationdeep learninghistologic imaging

Identifiers

PMID40361352
PMCPMC12071027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.